CXCR4 overexpression has been reported for multiple human tumor types, ranging from hematologic malignancies (e.g., multiple myeloma) to solid tumors, including breast, prostate, lung and colorectal cancer [4,5]. Here, CXCR4 is linked to AL amyloidosis.